INS and Insulin resistance: As this was a retrospective analysis based on routine clinical records, mechanistic biomarkers such as fasting insulin (for Homeostasis Model Assessment of Insulin Resistance), inflammatory cytokines (e.g., interleukin-6, tumor necrosis factor-alpha), or markers of oxidative stress were not collected.